Read More Pharma Industry News Bridge to Life’s HOPE clinical trial shows major cost and rejection benefits for liver transplants Bridge to Life’s HOPE trial shows reduced liver transplant costs and steroid-resistant rejection, strengthening the case for VitaSmart perfusion system adoption. bySoujanya RaviAugust 6, 2025